Lastest from Businesswire

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ: RVNC) investors concerning the Company’s possible violations of federal securities laws. On September 23, 2024, Revance disclosed in a filing with the U.S. Securities and Exchange Commission that it had "received a notice to remedy alleged material breaches, including breaches of the maximum levels of buffer stock and required ef

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) investors concerning the Company’s possible violations of the federal securities laws. If you suffered a loss on your Edwards Lifesciences investments or would like to inquire about potentially pursuing claims to recover your

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) investors concerning the Company’s possible violations of federal securities laws. On July 24, 2024, Edwards Lifesciences announced fiscal second quarter 2024 results which came in below expectations. The Company also announced lowered projections for its core Transcatheter Aortic Valve Replacement (TAVR) pla

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ: RVNC) investors concerning the Company’s possible violations of the federal securities laws. If you suffered a loss on your Revance investments or would like to inquire about potentially pursuing claims to recover your loss under the federal secur

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Snap Inc. (“Snap” or the “Company”) (NYSE: SNAP) investors concerning the Company’s possible violations of federal securities laws. On August 1, 2024, Snap announced its second quarter 2024 financial results, revealing quarterly revenue of $1,237 million. The Company also announced guidance for third quarter revenue in the range of “$1,335 million to $1,375 million, implying year-over-year rev

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Snap Inc. (“Snap” or the “Company”) (NYSE: SNAP) investors concerning the Company’s possible violations of the federal securities laws. If you suffered a loss on your Snap investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submi

LOS ANGELES--(BUSINESS WIRE)--EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) on behalf of investors concerning the Company’s possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On July 24, 2024, Edwards Lifesciences announced fiscal second quarter 2024 results which came in below expectations. The Company also announced lowere

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Snap Inc. (“Snap” or the “Company”) (NYSE: SNAP) on behalf of investors concerning the Company’s possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On August 1, 2024, Snap announced its second quarter 2024 financial results, revealing quarterly revenue of $1,237 million. The Company also announced guidance for third quarter revenue in

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Snap Inc. (“Snap” or the “Company”) (NYSE: SNAP) on behalf of investors concerning the Company’s possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On August 1, 2024, Snap announced its second quarter 2024 financial results, revealing quarterly revenue of $1,237 million. The Company also announced guidance for third quarter revenue in

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--FRMO Corp. (the “Company” or “FRMO”) (OTC Pink: FRMO) today reported its financial results for the 2025 first quarter ended August 31, 2024. Financial Highlights FRMO’s total book value as of August 31, 2024 was $503.1 million ($11.43 per share on a fully diluted basis), including $226.6 million of non-controlling interests. Excluding the non-controlling interests, book value was $276.6 million ($6.28 per share). This compares with total book value at the pr

LOS ANGELES--(BUSINESS WIRE)--LNW Investors Have Opportunity to Join Light & Wonder, Inc. Securities Fraud Investigation with the Schall Law Firm

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Iris Energy Limited (“Iris Energy” or the “Company”) (NASDAQ: IREN) investors concerning the Company’s possible violations of federal securities laws. On July 11, 2024, Culper Research (“Culper”) issued a report entitled “Iris Energy Ltd (IREN): A Prius at the Grand Prix” (the “Culper Report” or the “Report”). In the Report, Culper announced that it was “short [IREN], a bitcoin miner that now

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of ASML Holding N.V. (“ASML” or the “Company”) (NASDAQ: ASML) on behalf of investors concerning the Company’s possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On October 15, 2024, ASML published earnings for the third quarter of 2024, revealing quarterly bookings of €2.63 billion, a decline of 53% quarter-over-quarter. The Company also

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Iris Energy Limited (“Iris Energy” or the “Company”) (NASDAQ: IREN) investors concerning the Company’s possible violations of the federal securities laws. If you suffered a loss on your Iris Energy investments or would like to inquire about potentially pursuing claims to recover your loss under the federal secu

NEW YORK--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Foxx Development Holdings Inc. (Nasdaq: FOXX) (f/k/a Acri Capital Acquisition Corporation) concerning the Company and its directors’ and officers’ possible violations of state laws. If you own Foxx Development stock, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Tom Kennedy, o

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024. Edwards describes itself as an “international company that researches, develops, provides products and technologies for heart valve repair and replacement therapies, as well as critical care monitoring solutions.” For more information, su

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Longboard Pharmaceuticals, Inc. (NasdaqGM: LBPH) to H. Lundbeck A/S. Under the terms of the proposed transaction, shareholders of Longboard will receive $60.00 in cash for each share of Longboard that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate,

BRIDGEPORT, Conn.--(BUSINESS WIRE)--A Bridgeport jury has awarded Evan Plotkin and his wife Martha Barry-Plotkin $15 million in a verdict against pharmaceutical giant Johnson & Johnson (NYSE:JNJ) and several subsidiaries for damage linked to asbestos in the company’s talc-based Baby Powder. “This trial demonstrated once again that J&J knew its products would cause harm, but they chose to do the wrong thing time and time again,” said Mr. Plotkin’s attorney, Ben Braly of Dean Omar Branham

NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns preliminary ratings to the Class A Notes, Class B Notes and Class C Notes (together, the “Secured Notes”) issued by Alp CFO 2024, L.P (the “Issuer”). The total issuance amount is $1 billion, resulting in initial Loan-to-Value ratios of 50%, 65% and 75% for the Class A Notes, Class B Notes, and Class C Notes, respectively. The net proceeds of the transaction will be initially invested in an asset portfolio consisting of (1) limited partnership interests (“